{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-039083","form_type":"8-K","ticker":"IMCR","cik":"0001671927","company_name":"Immunocore Holdings plc","filed_at":"2024-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.046717+00:00","generated_at":"2026-05-31T06:59:57.914274+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Immunocore CFO Brian Di Donato resigns, effective Dec 31, 2024, to become CEO at private biotech","bullets":["CFO and Head of Strategy Brian Di Donato resigns effective Dec 31, 2024, to become CEO at a private early-stage biotech in San Diego.","Resignation not due to any disagreement with Immunocore on financials, internal controls, or policies.","Di Donato remains through year-end to ensure smooth transition; formal CFO search initiated.","Di Donato joined over 4 years ago, led IPO and built Finance department."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-039083","json":"https://secwatch.observer/filing/0001140361-24-039083.json","markdown":"https://secwatch.observer/filing/0001140361-24-039083.md","text":"https://secwatch.observer/filing/0001140361-24-039083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671927/000114036124039083/0001140361-24-039083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671927/000114036124039083/ef20035097_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:59:57.914274+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"64ba52561b","claim":"Brian Di Donato resigned as Chief Financial Officer at Immunocore Holdings plc.","evidence_excerpt":"Mr. Brian Di Donato notified Immunocore Holdings plc (the “Company”) of his decision to resign as Executive Vice President, Chief Financial Officer and Head of Strategy and principal financial officer of the Company, effective December 31, 2024, to pursue another opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671927/000114036124039083/0001140361-24-039083-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}